What is Inhibrx Biosciences, Inc. Common Stock's Market Cap?

Inhibrx Biosciences, Inc. Common Stock's Market Cap is $1.4B, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Enterprise Value?

Inhibrx Biosciences, Inc. Common Stock's Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's EV / EBITDA?

Inhibrx Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Revenue (TTM)?

Inhibrx Biosciences, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Net Income (TTM)?

Inhibrx Biosciences, Inc. Common Stock's Net Income (TTM) is -$138.2M, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's EBITDA?

Inhibrx Biosciences, Inc. Common Stock's EBITDA is -$125.6M, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Diluted EPS (TTM)?

Inhibrx Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -9.39, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Net Debt?

Inhibrx Biosciences, Inc. Common Stock's Net Debt is $42.9M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Inhibrx Biosciences, Inc. Common Stock

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00P80N9V6

93.38▼ 3.72 (-3.83%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 97.10
Day's Range: 92.50 – 96.99
52-Week Range: 28.16 – 155.00
Volume: 176.2K
Avg Volume: 237.0K

Share Statistics

Shares Outstanding
Employees: 110
Exchange: XNAS
Listed: 2024-05-28

Share count as of August 7, 2026

Inhibrx Biosciences, Inc. Common Stock (INBX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Inhibrx Biosciences, Inc. Common Stock (INBX)

What is Inhibrx Biosciences, Inc. Common Stock's Market Cap?: Inhibrx Biosciences, Inc. Common Stock's Market Cap is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Enterprise Value?: Inhibrx Biosciences, Inc. Common Stock's Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's EV / EBITDA?: Inhibrx Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Revenue (TTM)?: Inhibrx Biosciences, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Net Income (TTM)?: Inhibrx Biosciences, Inc. Common Stock's Net Income (TTM) is -$138.2M, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's EBITDA?: Inhibrx Biosciences, Inc. Common Stock's EBITDA is -$125.6M, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Diluted EPS (TTM)?: Inhibrx Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -9.39, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Net Debt?: Inhibrx Biosciences, Inc. Common Stock's Net Debt is $42.9M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · INBXAs-filed SEC (XBRL) data